What type of study is this?

This is a In Vitro Study study.

December 6, 2025Frontiers in ImmunologyOpen Access

Identification of MUC5B as a lymph node metastasis-associated gene in lung adenocarcinoma through integrated transcriptomic and machine learning approaches

View Full Paper

Ask AI

Bookmark

Authors

Analysis reveals MUC5B's role as a biomarker for lymph node metastasis in lung adenocarcinoma, suggesting therapeutic potential.

MUC5B serves as a critical biomarker influencing lymph node metastasis in lung adenocarcinoma.
The predictive model demonstrated high accuracy for metastasis identification, with an AUC greater than 0.9.
Transcriptional and immunohistochemical analyses confirmed MUC5B upregulation in metastatic cases, linking it to tumor progression.
Findings highlight a potential regulatory role of MUC5B in invasion and cell cycle processes within LUAD.

Du et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

December 6, 2025Frontiers in ImmunologyOpen Access

View Full Paper

Ask AI

Bookmark

Authors

Analysis reveals MUC5B's role as a biomarker for lymph node metastasis in lung adenocarcinoma, suggesting therapeutic potential.

MUC5B serves as a critical biomarker influencing lymph node metastasis in lung adenocarcinoma.
The predictive model demonstrated high accuracy for metastasis identification, with an AUC greater than 0.9.
Transcriptional and immunohistochemical analyses confirmed MUC5B upregulation in metastatic cases, linking it to tumor progression.
Findings highlight a potential regulatory role of MUC5B in invasion and cell cycle processes within LUAD.

Du et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark